ALINITY I NSE - COFEPRIS Registration 660R2022 SSA
Access comprehensive regulatory information for ALINITY I NSE (ALINITY I NSE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 660R2022 SSA and manufactured by ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on July 25, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ALINITY I NSE ES UN INMUNOANÁLISISQUIMIOLUMINISCENTE DE MICROPARTÍCULAS (CMIA)UTILIZADO PARA LA DETERMINACIÓN CUANTITATIVA DEENOLASA ESPECÍFICA DE NEURONA (NSE) EN SUEROHUMANOENALINITYISYSTEM. AGENTEDEDIAGNÓSTICOPARA USO IN VITRO. PARA USO EXCLUSIVO ENLABORATORIOS CLÍNICOS O DE GABINETE.
THE ALINITY I NSE ASSAY IS A MICROPARTICLE CHEMILUMINESCENT IMMUNOASSAY (CMIA) USED FOR THE QUANTITATIVE DETERMINATION OF NEURON-SPECIFIC ENOLASE (NSE) IN HUMAN SERUM ENALINITYISYSTEM. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR EXCLUSIVE USE IN CLINICAL OR CABINET LABORATORIES.